Zhejiang Starry Pharmaceutical Co.,Ltd.’s Net Profit Dropped 54.6% in First Half of 2022

Zhejiang Starry Pharmaceutical Co.,Ltd. (浙江司太立制药股份有限公司) (603520.SH) reported a net profit of 69.3 million yuan in the first half of 2022, down 54.6% year-on-year.

Meanwhile, the company posted 942.5 million yuan in revenue, up 10.2% year-on-year.

At the end of the reporting period, it had 5.2 billion yuan in total assets and 3.3 billion yuan in total liabilities, with a liability-to-asset ratio of 63.3%.